These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18338845)

  • 21. Computer-based de novo design of drug-like molecules.
    Schneider G; Fechner U
    Nat Rev Drug Discov; 2005 Aug; 4(8):649-63. PubMed ID: 16056391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular fields in drug discovery: getting old or reaching maturity?
    Cross S; Cruciani G
    Drug Discov Today; 2010 Jan; 15(1-2):23-32. PubMed ID: 19150413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B
    Drug Discov Today; 2008 Mar; 13(5-6):219-26. PubMed ID: 18342797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Desktop and conference room VR for physicians.
    Ai Z; Rasmussen M
    Stud Health Technol Inform; 2005; 111():12-4. PubMed ID: 15718690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shape Signatures: speeding up computer aided drug discovery.
    Meek PJ; Liu Z; Tian L; Wang CY; Welsh WJ; Zauhar RJ
    Drug Discov Today; 2006 Oct; 11(19-20):895-904. PubMed ID: 16997139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in distributed computing with modern drug discovery.
    Banegas-Luna AJ; Imbernón B; Llanes Castro A; Pérez-Garrido A; Cerón-Carrasco JP; Gesing S; Merelli I; D'Agostino D; Pérez-Sánchez H
    Expert Opin Drug Discov; 2019 Jan; 14(1):9-22. PubMed ID: 30484337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data management system for distributed virtual screening.
    Zhou T; Caflisch A
    J Chem Inf Model; 2009 Jan; 49(1):145-52. PubMed ID: 19072299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the use of open-source software applications in drug discovery.
    Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
    Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ImmunoGrid, an integrative environment for large-scale simulation of the immune system for vaccine discovery, design and optimization.
    Pappalardo F; Halling-Brown MD; Rapin N; Zhang P; Alemani D; Emerson A; Paci P; Duroux P; Pennisi M; Palladini A; Miotto O; Churchill D; Rossi E; Shepherd AJ; Moss DS; Castiglione F; Bernaschi M; Lefranc MP; Brunak S; Motta S; Lollini PL; Basford KE; Brusic V
    Brief Bioinform; 2009 May; 10(3):330-40. PubMed ID: 19383844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A grid computing-based approach for the acceleration of simulations in cardiology.
    Alonso JM; Ferrero JM; Hernández V; Moltó G; Saiz J; Trénor B
    IEEE Trans Inf Technol Biomed; 2008 Mar; 12(2):138-44. PubMed ID: 18348943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hunting for predictive computational drug-discovery models.
    Snow CD
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):291-3. PubMed ID: 18588493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State-of-the-art technology in modern computer-aided drug design.
    Dalkas GA; Vlachakis D; Tsagkrasoulis D; Kastania A; Kossida S
    Brief Bioinform; 2013 Nov; 14(6):745-52. PubMed ID: 23148324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interoperability of GADU in using heterogeneous grid resources for bioinformatics applications.
    Sulakhe D; Rodriguez A; Wilde M; Foster I; Maltsev N
    IEEE Trans Inf Technol Biomed; 2008 Mar; 12(2):241-6. PubMed ID: 18348953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in computer-aided drug discovery.
    Tropsha A
    Curr Opin Drug Discov Devel; 2000 May; 3(3):310-3. PubMed ID: 19649864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current developments in and importance of high-performance computing in drug discovery.
    Pitera JW
    Curr Opin Drug Discov Devel; 2009 May; 12(3):388-96. PubMed ID: 19396740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grid computing in large pharmaceutical molecular modeling.
    Claus BL; Johnson SR
    Drug Discov Today; 2008 Jul; 13(13-14):578-83. PubMed ID: 18598912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of accelerator processors for high-throughput molecular modeling and simulation.
    Giupponi G; Harvey MJ; De Fabritiis G
    Drug Discov Today; 2008 Dec; 13(23-24):1052-8. PubMed ID: 18762274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.